Assessment of DOT Spectacles in Chinese Children
NCT: NCT05562622 · ACTIVE_NOT_RECRUITING
Brief Summary
This is a randomized, controlled, evaluator-blinded, multicenter, two-arm parallel group clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses by comparing to single vision, impact-resistant spectacle lenses in reducing the progression of juvenile myopia in children of Chinese origin.
Frequently Asked Questions
What is Assessment of DOT Spectacles in Chinese Children?
Assessment of DOT Spectacles in Chinese Children is a clinical trial registered under NCT05562622. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05562622?
The current status of NCT05562622 (Assessment of DOT Spectacles in Chinese Children) is: ACTIVE_NOT_RECRUITING.
When did Assessment of DOT Spectacles in Chinese Children start?
Assessment of DOT Spectacles in Chinese Children started on 2023-02-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.